Skip to content
TED Community
Menu

What Is Thyroid Eye Disease? A Beginner’s Guide to TED

What Is Thyroid Eye Disease?

A Beginner’s Guide to TED

Thyroid Eye Disease (TED) — also known as Graves' Orbitopathy, Thyroid-Associated Orbitopathy, or Graves' Ophthalmopathy — is a rare autoimmune condition that affects the eyes and the tissues around them. It is most often associated with Graves’ disease, an autoimmune thyroid disorder that causes overproduction of thyroid hormones (hyperthyroidism).

What Causes TED?

TED occurs when the immune system mistakenly targets the muscles and soft tissues around the eyes. The immune response leads to inflammation and swelling, which can push the eyeball forward (a condition called proptosis or exophthalmos) and interfere with normal eye movements.

Importantly, TED can sometimes appear even when thyroid function is normal or has already been treated.

Common Symptoms

The symptoms of TED vary from mild to severe, and they may develop gradually or suddenly. Common signs include:

  • Bulging eyes (exophthalmos)

  • Redness and swelling of the eyelids

  • Eye pain or pressure

  • Dry eyes and excessive tearing

  • Double vision (diplopia)

  • Light sensitivity (photophobia)

  • Difficulty moving the eyes

  • In rare cases, vision loss due to optic nerve compression

These symptoms are caused by the buildup of inflammatory cells, fluid, and scar tissue in the orbit (eye socket).

Who Is at Risk?

TED affects around 25–50% of people with Graves’ disease. However, some risk factors make it more likely:

  • Smoking — the most significant modifiable risk factor. Smokers have a more severe form and worse response to treatment.

  • Middle age (30–60 years)

  • Female sex — though men may experience more severe disease

  • Stress or recent surgery

  • Family history of thyroid disease

Diagnosis

Diagnosis typically involves:

  • A clinical examination by an ophthalmologist or endocrinologist

  • Imaging tests (CT or MRI) to assess inflammation and changes in the eye muscles or orbital tissue

  • Blood tests to check thyroid hormone levels and thyroid antibodies

According to the EUGOGO guidelines (European Group on Graves’ Orbitopathy), TED is classified into mild, moderate-to-severe, and sight-threatening forms based on the severity and impact on vision.

How Is It Treated?

Treatment depends on the stage and severity of TED. Options include:

Supportive care:

  • Lubricating eye drops or ointments

  • Sunglasses for light sensitivity

  • Prism glasses to correct double vision

Medical treatments:

  • Corticosteroids (oral or intravenous) to reduce inflammation

  • Immunosuppressants for severe or unresponsive cases

  • Teprotumumab (Tepezza®) – a new biologic therapy approved in Europe for severe TED; it blocks the insulin-like growth factor-1 receptor and significantly improves proptosis and inflammation

Surgical treatments:

  • Orbital decompression surgery – removes bone/fat to relieve pressure

  • Strabismus surgery – aligns the eyes to reduce double vision

  • Eyelid surgery – corrects eyelid retraction or exposure

Smoking cessation is crucial at every stage. It significantly improves treatment outcomes and reduces the risk of progression.

What About TED in Belgium?

In Belgium, specialized care is available through major university hospitals such as UZ Leuven, UZ Brussel, and Ghent University Hospital, which are part of the ERN-EYE (European Reference Network for rare eye diseases).

Specialists like Dr. Vincent Qin (Brussels and Namur) focus on thyroid orbitopathy, and patients can find information and appointments through platforms like MediFind or Doctoranytime.be.

However, there is no dedicated TED patient organization in Belgium as of today. This highlights the need for patient education platforms and community initiatives.

Living with TED

Though TED can be distressing, early diagnosis, proper medical care, and lifestyle changes can help manage the disease and preserve vision. Many patients eventually reach a “plateau” phase where inflammation subsides and eye function stabilizes.

Support groups, psychological care, and understanding one’s condition are essential parts of long-term management.

References

  1. UZ Leuven – Oogziekte van Graves: https://www.uzleuven.be/nl/oogziekten/orbita-oogleden-en-traanwegen/oogziekte-van-graves

  2. Gezondheid.be – Oogziekte van Graves: https://www.gezondheid.be/artikel/oogziekten/oogziekte-van-graves-of-graves-orbitopathie-go-13470

  3. Dr. Vincent Qin – Thyroid Orbitopathy: https://www.drvincentqin.be/en/pathology/thyroid-orbitopathy/

  4. European Medicines Agency – First treatment against severe TED (Tepezza): https://www.ema.europa.eu/en/news/first-treatment-against-severe-thyroid-eye-disease

  5. Nature.com – The changing landscape of thyroid eye disease: https://www.nature.com/articles/s41433-024-02967-9

  6. MediFind – Top TED Doctors in Belgium: https://www.medifind.com/conditions/thyroid-eye-disease/6451/doctors/location/BE

  7. Keyword Study Report, June 2025

  8. SEO & Content Strategy Report, June 2025

¿Te gustaría que preparemos también las versiones del artículo en francés y holandés?